WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013054940) THERAPEUTIC AGENT AND PREVENTIVE AGENT FOR DEMYELINATING DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/054940    International Application No.:    PCT/JP2012/076746
Publication Date: 18.04.2013 International Filing Date: 10.10.2012
IPC:
A61K 31/426 (2006.01), A61P 13/12 (2006.01), A61P 19/06 (2006.01), A61P 25/00 (2006.01), A61P 37/00 (2006.01), C07D 277/20 (2006.01), C07D 277/56 (2006.01)
Applicants: OSAKA UNIVERSITY [JP/JP]; 1-1, Yamadaoka, Suita-shi, Osaka 5650871 (JP).
TEIJIN PHARMA LIMITED [JP/JP]; 2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo 1000013 (JP)
Inventors: NAKATSUJI, Yuji; (JP).
KINOSHITA, Makoto; (JP).
HONORAT, Josephe Archie; (JP).
SAKODA, Saburo; (JP)
Agent: TAMEYAMA, Taro; c/o Teijin Limited, 2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo 1000013 (JP)
Priority Data:
2011-223978 11.10.2011 JP
Title (EN) THERAPEUTIC AGENT AND PREVENTIVE AGENT FOR DEMYELINATING DISEASE
(FR) AGENT THÉRAPEUTIQUE ET AGENT PRÉVENTIF POUR UNE MALADIE DÉMYÉLINISANTE
(JA) 脱髄疾患の治療薬及び予防薬
Abstract: front page image
(EN)The purpose of the present invention is to provide a novel therapeutic agent and preventive agent for demyelinating disease. The present invention is a therapeutic agent and a preventive agent for demyelinating disease that contain as an active ingredient a 2-phenylthiazole compound represented by formula (I) or a medically acceptable salt thereof.
(FR)La présente invention a pour but de proposer un nouvel agent thérapeutique et un nouvel agent préventif pour une maladie démyélinisante. La présente invention concerne un agent thérapeutique et un agent préventif pour une maladie démyélinisante qui contiennent en tant qu'ingrédient actif un composé 2-phénylthiazole représenté par la formule (I) ou un sel médicalement acceptable de celui-ci.
(JA)本発明は、新規な脱髄疾患の治療薬又は予防薬を提供することを目的とする。本発明は、下記式(I) で表される2-フェニルチアゾール化合物又はそれらの医薬上許容される塩を有効成分として含有する 、脱髄疾患の治療薬又は予防薬である。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)